A detailed history of Morgan Stanley transactions in Optimize Rx Corp stock. As of the latest transaction made, Morgan Stanley holds 74,005 shares of OPRX stock, worth $740,050. This represents 0.0% of its overall portfolio holdings.

Number of Shares
74,005
Previous 77,928 5.03%
Holding current value
$740,050
Previous $1.12 Million 19.37%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$11.47 - $16.17 $44,996 - $63,434
-3,923 Reduced 5.03%
74,005 $899,000
Q4 2023

Feb 13, 2024

BUY
$7.06 - $14.49 $212,943 - $437,047
30,162 Added 63.15%
77,928 $1.12 Million
Q3 2023

Nov 15, 2023

BUY
$7.43 - $14.96 $148,637 - $299,274
20,005 Added 72.06%
47,766 $371,000
Q2 2023

Aug 14, 2023

SELL
$11.63 - $15.63 $1.16 Million - $1.56 Million
-99,576 Reduced 78.2%
27,761 $396,000
Q1 2023

May 15, 2023

SELL
$12.54 - $19.38 $546,493 - $844,580
-43,580 Reduced 25.5%
127,337 $1.86 Million
Q4 2022

Feb 14, 2023

SELL
$13.77 - $22.04 $427,310 - $683,945
-31,032 Reduced 15.37%
170,917 $2.87 Million
Q3 2022

Nov 14, 2022

BUY
$13.74 - $30.13 $480,501 - $1.05 Million
34,971 Added 20.94%
201,949 $2.99 Million
Q2 2022

Oct 27, 2022

BUY
$21.94 - $40.49 $139,165 - $256,828
6,343 Added 3.95%
166,978 $4.57 Million
Q2 2022

Aug 15, 2022

BUY
$21.94 - $40.49 $139,165 - $256,828
6,343 Added 3.95%
166,978 $4.57 Million
Q1 2022

Oct 27, 2022

SELL
$35.27 - $62.91 $223,717 - $399,038
-6,343 Reduced 3.8%
160,635 $6.06 Million
Q1 2022

May 13, 2022

SELL
$35.27 - $62.91 $997,964 - $1.78 Million
-28,295 Reduced 14.98%
160,635 $6.06 Million
Q4 2021

Feb 14, 2022

BUY
$53.57 - $98.0 $8.81 Million - $16.1 Million
164,498 Added 673.29%
188,930 $11.7 Million
Q3 2021

Nov 15, 2021

BUY
$50.93 - $85.55 $1.24 Million - $2.09 Million
24,432 New
24,432 $2.09 Million

Others Institutions Holding OPRX

About OptimizeRx Corp


  • Ticker OPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 18,023,100
  • Market Cap $180M
  • Description
  • OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...
More about OPRX
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.